MSB 4.07% $1.15 mesoblast limited

Hard to tell. The potency assay development for the confirmatory...

  1. 325 Posts.
    lightbulb Created with Sketch. 359
    Hard to tell. The potency assay development for the confirmatory heart trial, if one is needed as Dr. Perin has suggested, would be made much easier, of course, by a good understanding of the MoA and what biomarkers to use to predict and/or correlate with efficacy.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.